# Effect of RAS/MAPK Pathway Hyperactivation on Growth' and Bone' Profile of the RASopathies

> **NCT06331117** · NA · UNKNOWN · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 120 (estimated)

## Conditions studied

- RASopathy
- Costello Syndrome
- Noonan Syndrome
- Cardio-Facio-Cutaneous Syndrome

## Interventions

- **DIAGNOSTIC_TEST:** Diagnostic test

## Key facts

- **NCT ID:** NCT06331117
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-22
- **Primary completion:** 2021-12-22
- **Final completion:** 2026-04-22
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06331117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06331117, "Effect of RAS/MAPK Pathway Hyperactivation on Growth' and Bone' Profile of the RASopathies". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06331117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*